CD38 a biomarker and therapeutic target in non-hematopoietic tumors.
Sign Up to like & getrecommendations! Published in 2022 at "Biomarkers in medicine"
DOI: 10.2217/bmm-2021-0575
Abstract: The type II transmembrane glycoprotein CD38 has recently been implicated in regulating metabolism and the pathogenesis of multiple conditions, including aging, inflammation and cancer. CD38 is overexpressed in several tumor cells and microenvironment tumoral cells,… read more here.
Keywords: therapeutic target; cd38 biomarker; biomarker therapeutic; target non ... See more keywords